Quantitative Systematic Strategies’s Fate Therapeutics FATE Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-6,922
| Closed | -$601K | – | 137 |
|
2021
Q2 | $601K | Sell |
6,922
-4,651
| -40% | -$404K | 0.21% | 184 |
|
2021
Q1 | $954K | Buy |
11,573
+6,765
| +141% | +$558K | 0.15% | 241 |
|
2020
Q4 | $437K | Sell |
4,808
-11,593
| -71% | -$1.05M | 0.06% | 416 |
|
2020
Q3 | $656K | Buy |
16,401
+1,302
| +9% | +$52.1K | 0.11% | 266 |
|
2020
Q2 | $518K | Buy |
15,099
+2,623
| +21% | +$90K | 0.1% | 294 |
|
2020
Q1 | $277K | Sell |
12,476
-3,442
| -22% | -$76.4K | 0.23% | 162 |
|
2019
Q4 | $312K | Buy |
15,918
+5,462
| +52% | +$107K | 0.05% | 433 |
|
2019
Q3 | $162K | Buy |
+10,456
| New | +$162K | 0.04% | 421 |
|
2019
Q1 | – | Sell |
-13,216
| Closed | -$170K | – | 486 |
|
2018
Q4 | $170K | Buy |
+13,216
| New | +$170K | 0.04% | 549 |
|
2018
Q3 | – | Sell |
-11,350
| Closed | -$129K | – | 672 |
|
2018
Q2 | $129K | Buy |
+11,350
| New | +$129K | 0.02% | 587 |
|